Small RNAs not only cure T2DM but also extend lifespan: MiRNA-146b increases UCP protein expression, energy expenditure, glucose tolerance, insulin sensitivity and extends lifespan via down regulation of its target gene, 5/May/2015, 23.45

Molecular therapy for T2DM: EGFR enhances insulin secretion by increasing glucagon-like peptide-1 secretion via up regulation of its target gene, 5/May/2015, 23.23
May 5, 2015
Regenerating the lost cardiomyocytes in Myocardial patients: Pitavastatin/Livalo, an inhibitor of HMG-CoA reductase and a blood cholesterol lowering drug, increases the expression of ERBB2 and promotes dedifferentiation of cardiomyocytes via down regulation of its target gene, 5/May/2014, 23.57
May 5, 2015
Show all

A study from the Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Diabetes Unit, Medical Services, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; European Molecular Biology Laboratory, Mouse Biology Unit, 00015-Monterotondo, Italy; Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK etc.   shows that IGF2BP2/IMP2-Deficient Mice Resist Obesity through Enhanced Translation of Ucp1 mRNA and Other mRNAs Encoding Mitochondrial Proteins.” This study was published in the 7 Apr  2015 issue of the journal “Cell Metabolism” [the number 1 journal in field of Metabolism with an I.F of 16.747] by Prof. Joseph Avruch, Ning Dai,  and Others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Small RNAs not only cure T2DM but also extend lifespan: MiRNA-146b increases UCP protein expression, energy expenditure, glucose tolerance, insulin sensitivity and extends lifespan via down regulation of its target gene. 

Significance: This study suggests, for the first time, that MiRNA-146b, by decreasing the expression of its target gene, it may decrease diet-induced obesity, increase UCP protein expression, energy expenditure, cold tolerance, glucose tolerance, insulin sensitivity and extend lifespan.  Thus, pharmacological formulations encompassing MiRNA-146b or its activators” may be used to treat T2DM, promote lean mass, increase cold exposure tolerance and extend the life span of an individual.

Undisclosed information: How MiRNA-146b increases UCP protein expression, energy expenditure, glucose tolerance, insulin sensitivity and promotes longer lifespan

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Small RNAs not only cure T2DM but also extend lifespan:   MiRNA-146b increases UCP protein expression, energy expenditure, glucose tolerance, insulin sensitivity and extends lifespan via down regulation of its target gene, 5/May/2015,  23.45,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.